[Violence risk assessment in forensic patients using HCR-20v3: interrater reliability and concurrent validity]

Elisa Folino1, Karin Arbach2

  • 1Magister en Salud Mental Forense. Dirección General de Salud Penitenciaria, Ministerio de Justicia de la Provincia de Buenos Aires, Argentina.

Vertex (Buenos Aires, Argentina)
|November 16, 2021
PubMed
Summary

The Historical, Clinical and Risk Management-20, Version 3 (HCR-20V3) shows good reliability for assessing violence risk factors in forensic patients. Its validity is supported by correlations with other risk assessment tools.

Related Concept Videos

Reliability and Validity01:29

Reliability and Validity

Reliability and validity are two important considerations that must be made with any type of data collection. Reliability refers to the ability to consistently produce a given result. In the context of psychological research, this would mean that any instruments or tools used to collect data do so in consistent, reproducible ways.
13.3K
Relative Risk01:12

Relative Risk

Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
517
Hazard Ratio01:12

Hazard Ratio

The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
289